INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03FWFogarty Patrick W0B / 60S60 trades$277K
  4. 04SJSheena Jonathan0B / 57S57 trades$3.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 32S32 trades$5.48M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,584 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
2
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Option exercise · 10b5-1 plan
M$52K
13.6K sh
Jan 20, 2026Jan 22, 2026
Page 1424 of 1790
← PrevNext →
traded Jan 20, 2026
+2d
SEC Form 4

Evidence

2
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Option exercise · 10b5-1 plan
M$135K
32.7K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

1
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$167K
4,048 sh
Jan 22, 2026Jan 22, 2026
traded Jan 22, 2026
+0dSEC Form 4

Evidence

1
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$68K
1,700 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
37.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
16.2K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
856 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Option exercise · 10b5-1 plan
M—
41.3K sh
Jan 22, 2026Jan 22, 2026
traded Jan 22, 2026
+0dSEC Form 4

Evidence

0
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
37.1K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
8,425 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
856 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
44.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Sheena JonathanDirector, CO-FOUNDER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
191 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$8,455
210 sh
Jan 21, 2026Jan 22, 2026
traded Jan 21, 2026
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MP
Mauch Robert P.Director, President & CEO
CORCencora, Inc.
Option exercise · 10b5-1 plan
M—
3,763 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
8,888 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Option exercise · 10b5-1 plan
M—
32.7K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Option exercise · 10b5-1 plan
M$138K
7,562 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
KA
Kelly John AlexanderChief Financial Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
3,888 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
2,500 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
10.4K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AP
Adarkar PrabirPRESIDENT AND COO
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M$107K
15.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence